Sustained efficacy and safety of a 300IR daily dose of a sublingual solution of birch pollen allergen extract in adults with allergic rhinoconjunctivitis: results of a double-blind, placebo-controlled study (Q37591378)

From Wikidata
Jump to navigation Jump to search
scientific article published on 11 February 2014
edit
Language Label Description Also known as
English
Sustained efficacy and safety of a 300IR daily dose of a sublingual solution of birch pollen allergen extract in adults with allergic rhinoconjunctivitis: results of a double-blind, placebo-controlled study
scientific article published on 11 February 2014

    Statements

    Sustained efficacy and safety of a 300IR daily dose of a sublingual solution of birch pollen allergen extract in adults with allergic rhinoconjunctivitis: results of a double-blind, placebo-controlled study (English)
    Sabina Rak
    Frédéric de Blay
    Hans-Jorgen Malling
    Michel Melac
    Véronique Cadic
    Robert K Zeldin
    11 February 2014

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit